I am a cancer biologist whose research focuses on how lipid metabolism drives tumor progression, immune dysfunction, and therapy resistance. I earned my PhD at Daegu University and subsequently completed postdoctoral training at several leading research institutions. My research interests lie at the intersection of lipid metabolism and immune dysfunction in cancer, with a particular focus on intrahepatic cholangiocarcinoma (iCCA), an aggressive malignancy with limited treatment options. I am interested in how lipid metabolic reprogramming enables tumor cells to resist chemotherapy and evade immune surveillance.